Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hollander, A. A.
Right arrow Articles by van der Woude, F. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hollander, A. A.
Right arrow Articles by van der Woude, F. J.

Journal of the American Society of Nephrology, Vol 8, 294-301, Copyright © 1997 by American Society of Nephrology

REGULAR ARTICLES

Late prednisone withdrawal in cyclosporine-treated kidney transplant patients: a randomized study

AA Hollander, RJ Hene, J Hermans, LA van Es and FJ van der Woude
Department of Nephrology, University Hospital Leiden, The Netherlands.

Prednisone in combination with cyclosporine and/or azathioprine is commonly used after kidney transplantation to prevent graft rejection. Long-term use of prednisone can give rise to multiple side effects and morbidity. This randomized study was conducted to find out if prednisone could be withdrawn in recipients at least 1 yr after kidney transplantation. Eighty-four such recipients of a cadaveric kidney with stable renal function on cyclosporine and prednisone were randomized to continue prednisone (N = 42) or to withdraw prednisone in a 2-month period (N = 42). The main end point was the percentage of successful prednisone withdrawal. Both groups were compared for the incidence of infections and cardiovascular risk factors and for the incidence and cause of deterioration of renal function. All patients had a 14-month follow-up. In 67% (N = 28) of the patients, prednisone could be withdrawn successfully. Acute rejection was the main cause of withdrawal failure (N = 11, 26%). No grafts were lost due to rejection. In the prednisone withdrawal group, a tendency was noted for a lower incidence of infections (difference: 17%; 95% confidence interval [CI]: -4% to 37%). After withdrawal, less antihypertensive drugs were necessary to control hypertension (difference: 0.5 drugs/patient; 95% CI: -0.9 to -0.1) and 35% less patients (23 of 41 versus nine of 42) needed cholesterol-lowering drugs (95% CI: -54% to -15%). A reduction of the frequency of patients with Type II diabetes mellitus was found (difference 10%; 95% CI: -24% to 5%) with a decrease of glycosylated hemoglobin (difference: 0.4 mmol/L; 95% CI: 0.1 to 0.8). Disappearance of moonface was found in 25% of the patients. Elective withdrawal of prednisone > 1 yr after postmortal kidney transplantation can be accomplished safely provided that patients are controlled frequently. Beneficial effects were found regarding hypertension, hypercholesterolemia, hyperglycemia, and appearance.


This article has been cited by other articles:


Home page
 The Annals of PharmacotherapyHome page
S. Lam, N. Partovi, L. S. Ting, and M. H. Ensom
Corticosteroid Interactions with Cyclosporine, Tacrolimus, Mycophenolate, and Sirolimus: Fact or Fiction?
Ann. Pharmacother., July 1, 2008; 42(7): 1037 - 1047.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
J. M. Grinyo
Steroid sparing strategies in renal transplantation
Nephrol. Dial. Transplant., October 1, 2005; 20(10): 2028 - 2031.
[Full Text] [PDF]

Home page
 Diabetes CareHome page
J. A Davidson and A. Wilkinson
New-Onset Diabetes After Transplantation 2003 International Consensus Guidelines: An endocrinologist's view
Diabetes Care, March 1, 2004; 27(3): 805 - 812.
[Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
E. Gotti, N. Perico, A. Perna, F. Gaspari, D. Cattaneo, R. Caruso, S. Ferrari, N. Stucchi, G. Marchetti, M. Abbate, et al.
Renal Transplantation: Can We Reduce Calcineurin Inhibitor/Stop Steroids? Evidence Based on Protocol Biopsy Findings
J. Am. Soc. Nephrol., March 1, 2003; 14(3): 755 - 766.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
P. J. H. Smak Gregoor, R. G. L. de Sevaux, G. Ligtenberg, A. J. Hoitsma, R. J. Hene, W. Weimar, L. B. Hilbrands, and T. van Gelder
Withdrawal of Cyclosporine or Prednisone Six Months after Kidney Transplantation in Patients on Triple Drug Therapy: A Randomized, Prospective, Multicenter Study
J. Am. Soc. Nephrol., May 1, 2002; 13(5): 1365 - 1373.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
B. L. KASISKE, H. A. CHAKKERA, T. A. LOUIS, and J. Z. MA
A Meta-Analysis of Immunosuppression Withdrawal Trials in Renal Transplantation
J. Am. Soc. Nephrol., October 1, 2000; 11(10): 1910 - 1917.
[Abstract] [Full Text]

Home page
 J. Am. Soc. Nephrol.Home page
B. L. KASISKE, M. A. VAZQUEZ, W. E. HARMON, R. S. BROWN, G. M. DANOVITCH, R. S. GASTON, D. ROTH, J. D. SCANDLING JR., and G. G. SINGER
Recommendations for the Outpatient Surveillance of Renal Transplant Recipients
J. Am. Soc. Nephrol., October 1, 2000; 11(2007): S1 - S86.
[Abstract] [Full Text] [PDF]


HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP

Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673